ConductScience.org, home

Paper797499

Propranolol disposition in chronic liver disease: a physiological approach.

Branch RA and 1 other. Clin Pharmacokinet, 1976. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Propranolol disposition in chronic liver disease: a physiological approach. Papers, record 797499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/797499

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Propranolol disposition in chronic liver disease: a physiological approach.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3.98
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Branch RAR A
2Shand DGD G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver DiseasesMajor topic
PropranololMajor topic
Administration, Oral
Blood Proteins
Chronic Disease
Half-Life
Humans
Kinetics
Liver
Liver Cirrhosis
Portacaval Shunt, Surgical
Protein Binding

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15299657A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation.Am J Surg1968https://conductscience.org/library/papers/5299657PubMed
213689739The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin Sci1961https://conductscience.org/library/papers/13689739PubMed
34657981The disposition of propranolol. II. Hepatic elimination in the rat.Pharmacology1972https://conductscience.org/library/papers/4657981PubMed
45041658Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites.J Pharmacol Exp Ther1972https://conductscience.org/library/papers/5041658PubMed
54564238Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic.Am J Med1972https://conductscience.org/library/papers/4564238PubMed
64203721Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4203721PubMed
84631471The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4631471PubMed
94564239Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease.Am J Med1972https://conductscience.org/library/papers/4564239PubMed
104729926Determinants of serum antipyrine half-lives in patients with liver disease.Gut1973https://conductscience.org/library/papers/4729926PubMed
1113809697Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.J Clin Invest1960https://conductscience.org/library/papers/13809697PubMed
121096786Pharmacokinetics of drug disposition: hemodynamic considerations.Annu Rev Pharmacol1975https://conductscience.org/library/papers/1096786PubMed
134817249Proceedings: The relation between cytochrome P450 in liver biopsies and drug metabolism in patients with liver disease and in morphine addiction.Clin Sci Mol Med1974https://conductscience.org/library/papers/4817249PubMed
144629296Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate.Am Heart J1973https://conductscience.org/library/papers/4629296PubMed
154723255Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723255PubMed
164764426Clearance concepts in pharmacokinetics.J Pharmacokinet Biopharm1973https://conductscience.org/library/papers/4764426PubMed
174890511A controlled study of the prophylactic portacaval shunt. A final report.Ann Intern Med1969https://conductscience.org/library/papers/4890511PubMed
201195129Effects of route of administration and blood flow on hepatic drug elimination.J Pharmacol Exp Ther1975https://conductscience.org/library/papers/1195129PubMed
215054586The disposition of propranolol. I. Elimination during oral absorption in man.Pharmacology1972https://conductscience.org/library/papers/5054586PubMed
224830012Letter: Effect of plasma protein binding on elimination of warfarin.J Pharm Sci1974https://conductscience.org/library/papers/4830012PubMed
236031788Metabolism of propranolol ('Inderal'), a potent, specific beta-adrenergic receptor blocking agent.Nature1967https://conductscience.org/library/papers/6031788PubMed

See all 44 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
24906133A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.PLoS One2014https://conductscience.org/library/papers/24906133PubMed
17328584Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.Clin Pharmacokinet2007https://conductscience.org/library/papers/17328584PubMed
16898077H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage.Eur J Drug Metab Pharmacokinet2006https://conductscience.org/library/papers/16898077PubMed
15656697The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.Clin Pharmacokinet2005https://conductscience.org/library/papers/15656697PubMed
11318520Time-dependent modifications of splanchnic circulation in female pigs submitted to end-to-side portacaval anastomosis.Dig Dis Sci2001https://conductscience.org/library/papers/11318520PubMed
10219840Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.Dig Dis Sci1999https://conductscience.org/library/papers/10219840PubMed
9592620The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.Clin Pharmacokinet1998https://conductscience.org/library/papers/9592620PubMed
9489593Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9489593PubMed
9021109Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study.Eur J Nucl Med1997https://conductscience.org/library/papers/9021109PubMed
8827399Influence of diet and nutritional status on drug metabolism.Clin Pharmacokinet1996https://conductscience.org/library/papers/8827399PubMed
8582120Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.Clin Pharmacokinet1995https://conductscience.org/library/papers/8582120PubMed
7988103Assessment of liver metabolic function. Clinical implications.Clin Pharmacokinet1994https://conductscience.org/library/papers/7988103PubMed
7389537Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.Dig Dis Sci1980https://conductscience.org/library/papers/7389537PubMed
7378257Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7378257PubMed
7174791Assessment of liver microcirculation in human cirrhosis.J Clin Invest1982https://conductscience.org/library/papers/7174791PubMed
7014827A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7014827PubMed
6995129Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6995129PubMed
6529530Drug metabolism in diabetic subjects with fatty livers.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6529530PubMed
6362950First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362950PubMed
6102499Clinical relevance of pharmacokinetics.Clin Pharmacokinet1980https://conductscience.org/library/papers/6102499PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/797499

GET https://conductscience.org/api/papers/v1/797499/references?page=2